An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia

NCT01646827 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Aripiprazole IM Depot

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.